Application of cell-based therapies in facial transplantation

Annals of Plastic Surgery

Volumn 69, Issue 5, 2012, Pages 575-579

  Siemionow, Maria ^a   Madajka, Maria ^a   Cwykiel, Joanna ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

adipose stem cells; bone marrow cells; cellular therapy; dendritic cells; face transplant; fusion cells; immunosuppression; T regulatory cells

Indexed keywords

ARTICLE; CELL TRANSPLANTATION; FACIAL TRANSPLANTATION; HUMAN; METHODOLOGY;

CELL TRANSPLANTATION; FACIAL TRANSPLANTATION; HUMANS;

EID: 84868676533     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31824803a5     Document Type: Article

References (59)

1. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230-247.
2. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988;136:42-60.
3. Krebsbach PH, Kuznetsov SA, Bianco P, et al. Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med. 1999;10: 165-181. (Pubitemid 29449535)
4. Steinhardt Y, Aslan H, Regev E, et al. Maxillofacial-derived stem cells regenerate critical mandibular bone defect. Tissue Eng Part A. 2008;14:1763-1773.
5. Mankani MH, Kuznetsov SA, Wolfe RM, et al. In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells. 2006;24:2140-2149. (Pubitemid 44477139)
6. Mankani MH, Kuznetsov SA, Shannon B, et al. Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol. 2006;168:542-550. (Pubitemid 43271152)
7. Devauchelle B, Badet L, Lengele B, et al. First human face allograft: early report. Lancet. 2006;368:203-209. (Pubitemid 44037773)
8. Hequet O, Morelon E, Bourgeot JP, et al. Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor. Bone Marrow Transplant. 2008;41:1059-1061. (Pubitemid 352034180)
9. Hausman GJ, Campion DR, McNamara JP, et al. Adipose tissue development in the fetal pig after decapitation. J Anim Sci. 1981;53:1634-1644.
10. Caillat-Zucman S, Legendre C, Suberbielle C, et al. Microchimerism frequency two to thirty years after cadaveric kidney transplantation. Hum Immunol. 1994; 41:91-95. (Pubitemid 24319057)
11. Suberbielle C, Caillat-ZucmanS, Legendre C, et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet. 1994;343:1468-1469. (Pubitemid 24176336)
12. Arslan E, Klimczak A, Siemionow M. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells. Microsurgery. 2007;27:190-199. (Pubitemid 46608881)
13. Klimczak A, Agaoglu G, Carnevale KA, et al. Applications of bilateral vas-cularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II. Ann Plast Surg. 2006;57: 422-430. (Pubitemid 44450584)
14. Robey PG, Bianco P. The use of adult stem cells in rebuilding the human face. J Am Dent Assoc. 2006;137:961-972. (Pubitemid 44153896)
15. Hausman GJ. Adipocyte development in subcutaneous tissues of the young rat. Acta Anat (Basel). 1982;112:185-196. (Pubitemid 12122424)
16. Loffler G, Hauner H. Adipose tissue development: the role of precursor cells and adipogenic factors. Part II: The regulation of the adipogenic conversion by hormones and serum factors. Klin Wochenschr. 1987;65:812-817.
17. Hauner H, Loffler G. Adipose tissue development: the role of precursor cells and adipogenic factors. Part I: Adipose tissue development and the role of precursor cells. Klin Wochenschr. 1987;65:803-811. (Pubitemid 17123337)
18. Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109:656-663. (Pubitemid 38198874)
19. Izadpanah R, Trygg C, Patel B, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006;99: 1285-1297.
20. Keyser KA, Beagles KE, Kiem HP. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant. 2007; 16:555-562. (Pubitemid 351448291)
21. Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg. 2008;32:48-55; discussion 56-47.
22. Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009;52:79-86.
23. Madonna R, De Caterina R. Adipose tissue: a new source for cardiovascular repair. J Cardiovasc Med (Hagerstown). 2010;11:71-80.
24. Jumabay M, Matsumoto T, Yokoyama S, et al. Dedifferentiated fat cells convert to cardiomyocyte phenotype and repair infarcted cardiac tissue in rats. J Mol Cell Cardiol. 2009;47:565-575.
25. Tran TT, Kahn CR. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol. 2010;6:195-213.
26. Yanez R, Lamana ML, Garcia-Castro J, et al. Adipose tissue-derived mesen-chymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells. 2006;24:2582-2591. (Pubitemid 44674320)
27. Gonzalez MA, Gonzalez-Rey E, Rico L, et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology. 2009;136:978-989.
28. Lu F, Mizuno H, Uysal CA, et al. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg. 2008; 121:50-58.
29. Coleman SR. Facial augmentation with structural fat grafting. Clin Plast Surg. 2006;33:567-577. (Pubitemid 44679715)
30. Wang M, Crisostomo PR, Herring C, et al. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2006;291:R880-R884. (Pubitemid 44498426)
31. Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289:F31-F42. (Pubitemid 40863570)
32. Agaoglu G, Carnevale KA, Zins JE, et al. Bilateral vascularized femoral bone transplant: a new model of vascularized bone marrow transplantation in rats, part I. Ann Plast Surg. 2006;56:658-664. (Pubitemid 43833044)
33. Demir Y, Ozmen S, Klimczak A, et al. Tolerance induction in composite facial allograft transplantation in the rat model. Plast Reconstr Surg. 2004;114: 1790-1801. (Pubitemid 40361890)
34. Ozmen S, Ulusal BG, Ulusal AE, et al. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies. Ann Plast Surg. 2006;56:295-300.
35. Siemionow M, Ulusal BG, Ozmen S, et al. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation. Microsurgery. 2004;24:200-206. (Pubitemid 38720802)
36. Ozer K, Gurunluoglu R, Zielinski M, et al. Extension of composite tissue allograft survival across major histocompatibility barrier under short course of anti-lymphocyte serum and cyclosporine a therapy. J Reconstr Microsurg. 2003;19:249-256.
37. Ozer K, Oke R, Gurunluoglu R, et al. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment. Transplantation. 2003;75:31-36. (Pubitemid 36139691)
38. Siemionow MZ, Izycki DM, Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation. 2003;76:1662-1668. (Pubitemid 38032410)
39. Shevach EM. Suppressor T cells: rebirth, function and homeostasis. Curr Biol. 2000;10:R572-R575. (Pubitemid 30647615)
40. Shevach EM. Regulatory T cells in autoimmmunity. Annu Rev Immunol. 2000; 18:423-449. (Pubitemid 30365387)
41. + cells in the recipient. Int Immunol. 2006;18:279-289. (Pubitemid 43160141)
42. Dorsch S, Roser R. Recirculating, suppressor T cells in transplantation tolerance. J Exp Med. 1977;145:1144-1157. (Pubitemid 8105360)
43. Jameson J, Havran WL. Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol Rev. 2007;215:114-122. (Pubitemid 46212234)
44. Langenkamp A, Casorati G, Garavaglia C, et al. T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur J Immunol. 2002;32:2046-2054. (Pubitemid 34814562)
45. Kedl RM, Rees WA, Hildeman DA, et al. T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med. 2000;192:1105-1113.
46. Du JF, Li SY, Yu B, et al. T(reg)-based therapy and mixed chimerism in small intestinal transplantation: Does T(reg)+BMT equal intestine allograft tolerance? Med Hypotheses. 2011;76:77-8.
47. + regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after alloge-neic hematopoietic stem cell transplantation. Sci Transl Med. 2010;2:41ra52.
48. Fandrich F. Cell therapy approaches aiming at minimization of immunosup-pression in solid organ transplantation. Curr Opin Organ Transplant. 2010 Oct 7. [Epub ahead of print].
49. Barski G, Sorieul S, Cornefert F. "Hybrid" type cells in combined cultures of two different mammalian cell strains. J Natl Cancer Inst. 1961;26:1269-1291.
50. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-545. (Pubitemid 34288856)
51. Ying QL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature. 2002;416:545-548. (Pubitemid 34288857)
52. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell. 2002;111:589-601. (Pubitemid 35356563)
53. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepato-cytes. Nature. 2003;425:968-973. (Pubitemid 37376928)
54. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003;422:897-901. (Pubitemid 36520042)
55. Anderson JM. Multinucleated giant cells. Curr Opin Hematol. 2000;7:40-47. (Pubitemid 30007686)
56. Merkel KD, Erdmann JM, McHugh KP, et al. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol. 1999;154:203-210. (Pubitemid 29031627)
57. Siemionow MZ, Demir Y, Sari A, et al. Facial tissue allograft transplantation. Transplant Proc. 2005;37:201-204. (Pubitemid 40459735)
58. Rahhal DN, Xu H, Huang WC, et al. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone. Transplantation. 2009;88:773-781.
59. Bonde S, Pedram M, Stultz R, et al. Cell fusionof bone marrow cells and somatic cell reprogramming by embryonic stem cells. FASEB J. 2010;24:364-373.